Skip to main content

Argentina’s Government Launches Public Company To Provide Cannabis Seeds, Testing, And Training

Earlier this month Argentina’s government issued its first-ever license for domestic cannabis production. It was a big milestone for Argentina’s domestic cannabis industry. Another significant announcement was made this month by Argentina’s government which could have international implications.

Days ago Argentina’s government announced the launch of a new national company dedicated to pushing the nation’s cannabis industry forward. The company, called ‘Cannabis Conicet,’ will focus on providing the nation’s emerging cannabis industry with genetics, testing, and training. Per excerpts from InfoBae:

The legal cannabis universe is expanding rapidly. The Argentine State presented this Tuesday “Cannabis Conicet”, a national technology-based company dedicated to the marijuana plant industry, made up and directed by scientists from the organization, with the idea of ​​”allowing the democratization of production, distribution and access to cannabis and the hemp industry”, as announced by the Minister of Science and Technology, Daniel Filmus, during the premiere day.

The public company will be made up of professionals from the National Council for Scientific and Technical Research (Conicet), the Arturo Jauretche National University (UNAJ) and the El Cruce Dr. Néstor Kirchner Hospital, but its authorities project that it will be a collective and federal work.

The new company seems to be primarily focused on the domestic industry in Argentina, with the ultimate goal right now appearing to be reducing Argentina’s reliance on the international cannabis community. For example, the term ‘scientific sovereignty’ was used by Ana Franchi, president of the Conicet, as part of the company’s announcement.

The development of tailored cannabis genetics, products, and other forms of intellectual property are going to play a very prominent role in the emerging cannabis industry going forward, and from that perspective, what Argentina is doing is a smart move.

Countries that solely rely on importing medical cannabis products from afar, which some nations currently do, will put those countries at a huge disadvantage once lawmakers finally decide to get on the right side of history.

While lawmakers that fit that description continue to drag their feet on cannabis reform and embracing the emerging cannabis industry domestically, countries like Argentina are stepping up their research and other scientific efforts. An opportunity cost clearly exists, and countries that are sitting on their hands need to get with the program as soon as possible.

Prime Minister Of Saint Kitts And Nevis Predicts Busy Year For Domestic Cannabis Industry

The Caribbean region has long been home to a vibrant cannabis community. Jamaica is likely the first Caribbean nation that comes to mind when someone thinks of cannabis, however, several other nations are also home to robust cannabis communities.

Thanks to cannabis reform measures being passed, many Caribbean nations are also now home to emerging cannabis industries, although the dual island nation of Saint Kitts and Nevis is unfortunately not one of those. If the country’s new prime minister has his way, things will be changing soon.

Current Saint Kitts and Nevis Prime Minister Terrance Drew was originally elected to the National Assembly last August. Prime Minister Drew has wasted no time in coming out swinging in support of cannabis reform and launching a domestic cannabis industry. Per excerpts from The Voice:

ST KITTS and Nevis could become the latest Caribbean nation to establish a medical cannabis industry.

Prime Minister Terrance Drew told the St Kitts-Nevis Information Service that the country was behind other Caribbean countries in developing a medical cannabis industry.

“Antigua is ahead, St Vincent is ahead, Jamaica is ahead, and we know that people travel to these countries because they would have an industry that is well-controlled, well-monitored and so forth that allows for the use of marijuana.

And so, we will be on that path, and we will see a lot of action in that area within the first year,” he said.

Prime Minister Drew went on to explain different phases that the nation needs to pursue, with the goal of having a regulated industry that benefits the country’s citizens. Drew specifically mentioned that the nation would not be looking for outside help, and instead will try to create an industry relying solely on domestic resources in order to maximize the benefits and opportunities for citizens.

Saint Kitts and Nevis is a part of what is called the Citizenship by Investment program. Several other Caribbean nations are also part of the program, which involves offering fast-track citizenships to foreign investors in exchange for them making socio-economic contributions to the country that they are applying to.

Prime Minister Drew is hoping that the cannabis industry can reduce the nation’s reliance on the program.

Far More Britons Want Cannabis Laws Loosened Compared To Tightened

Cannabis policy discussions in London have made considerable headlines in recent weeks, with London Mayor Sadiq Khan currently in somewhat of a political showdown with some of his political peers.

Mayor Khan is exploring the idea of reforming the way that law enforcement handles simple cannabis possession in London. The policy exploration is part of the work that a newly formed commission is performing at the behest of Mayor Khan. He recently indicated that calls from his political peers to refrain from pursuing the work would not deter him.

Additional headlines were made when it was reported that Home Secretary Suella Braverman was considering changing cannabis’ classification level to a more restricted status. The Prime Minister’s office has since made it clear that what is being reported will not happen, although it’s still unclear to what degree Braverman wants to pursue the concept in the future, if at all.

YouGov recently conducted a poll, asking Britons, “Do you think that the current cannabis laws should be tougher, less tough, or are about right?”

“Home secretary Suella Braverman has been reportedly planning to change cannabis from a class B drug to a class A But only 23% of Britons want to see cannabis laws made tougher, with 42% wanting less tough laws, and 19% thinking they’re ok as they are.” YouGov tweeted regarding the poll’s results.

Sixteen percent of poll participants indicated that they ‘don’t know’ in response to the question being posed to them. Obviously, 42% is not a majority, and for that matter the poll was not legally binding in any way.

However, the fact that only 23% of Britons indicated that they wanted cannabis laws to be made tougher is encouraging, and something that shouldn’t be ignored by lawmakers.

New Zealand Justice Minister Throws Cold Water On Cannabis Reform Hopes

Last week United States President Joe Biden announced a plan to issue pardons to people convicted of a federal cannabis possession charge. The plan is estimated to affect as many as 6,500 people, although only time will tell what the final number ends up being.

In the meantime, other elected officials around the globe are chiming in on the matter, with many demanding that their own nations take similar action as the U.S. did. One of those nations is New Zealand, however, New Zealand’s Justice Minister made it clear that there are no plans to do so any time soon.

Pointing To Prior Measures

New Zealand Green Party drug reform spokesperson Chlöe Swarbrick appears to be leading the charge when it comes to demands for cannabis reform in New Zealand. Swarbrick referred to the United States as ‘the birthplace of the war on drugs,’ and that if the United States can pursue federal cannabis reform, then so too can New Zealand.

In response to those calls for reform, Justice Minister Kiri Allan pointed to a prior reform measure that was passed in 2019 giving law enforcement some discretion over how to penalize people for cannabis. Minister Allan also pointed to the results of the 2020 referendum measure vote as justification for not pursuing further reform.

“We have a slightly different context here. In 2019, we introduced the ability for the police to exercise discretion when it came to possession of cannabis offences,” Minister Allan stated according to RNZ. “Subsequently, we’ve seen a radical reduction in terms of those that are convicted merely for cannabis possession.”

A Breeding Ground For Selective Enforcement

Giving law enforcement the ability to issue a fine in lieu of arresting someone for cannabis is obviously better than requiring law enforcement to arrest someone for cannabis. However, providing the multiple options and still giving law enforcement the ability to arrest some people and not others is a breeding ground for selective enforcement. It’s great that convictions are down in New Zealand, yet it would clearly be better if the convictions were zero.

It’s very unfortunate that so many elected officials in New Zealand appear to be pushing the talking point that the outcome of the 2020 referendum is absolute, as if it was the final answer when it comes to cannabis policy in New Zealand. That talking point completely disregards the fact that the outcome was extremely close, and that 48.4% of people voted for the measure (1,406,973 people). Cannabis policies are evolving in many places across the globe, and that needs to happen in New Zealand as well.

Europe’s Most Cannabis-Friendly Country

By Alex Rogers

Not long ago, just the mention of the words ‘Europe’ and ‘cannabis’ conjured up one name and image only – Amsterdam. While the police were busting down doors and arresting people left and right in most other countries around the world, Holland was a cannabis Valhalla of sorts. A place where you could be left alone to smoke your weed in peace, sans disruption, sans incarceration. For the last ten years Spain has, by some people’s assessment, taken over Holland’s venerable spot as the number one cannabis destination in Europe, as coffeeshop style venues have popped up all over the country, particularly in the city of Barcelona.

That all being said, neither The Netherlands nor Spain are Europe’s most cannabis friendly country. In fact, the irony is that Dutch and Spanish cannabis users are still looked down upon by the majority of their fellow citizens. Only deep in these countries’ urban enclaves is the culture of using cannabis looked upon as ‘no big deal.’

The Dutch and Spanish cannabis clubs are frequented by tourists, and the locals that hang out in the coffeeshops/clubs are often looked upon by their respective societies as ‘fringe.’ If a colleague from work catches them coming out of a coffee shop, it could be a slight embarrassment. Cannabis, though quasi-legal in Holland and Spain, is still stigmatized to a high degree.

There is one little gem of a country in Europe, tucked between the Mediterranean Sea and the Alps, where most of the entire country seems to be OK with cannabis use. That country is Slovenia. I have spent extensive time in Slovenia, as I have in Holland, and I have never seen a place in Europe where cannabis use was not only de-stigmatized, but also seemingly promoted by the majority of society in some way or another. Many family households in Slovenia even grow a few plants outside in the summer. Oftentimes Slovenians have even shown me pictures of their grandmas in the garden tending to cannabis. Slovenia is a green land (literally) with 65% of the country covered by forest. It looks like Switzerland, but has half the population density.

It is an agricultural society, and cannabis is looked at merely as another product that the Slovenians get from their beautiful mother earth, along with their wine, olives, honey, wild mushrooms and herbs, ubiquitous home vegetable gardens and abundant fruit trees. Slovenia is a literal garden of Eden, and if you like cannabis, it is in abundance and not expensive. Rick Simpson oil is known by the entire country. They don’t necessarily see it as a miracle cure for cancer, but rather, an aide to help the healing process ensue. The oil is readily available in Slovenia, and the government turns a compassionate eye to it, as it is used mainly for very sick people that need non-invasive treatment with non-detrimental side effects.

The capital city of Ljubljana feels like a little Prague with ever so slight hints of Berlin. It is a small city, but jammed packed with things to do. There are more outdoor cafes here per capita than almost any other European city. And, as far as I can tell, weed is effectively legal in Slovenia, or at least it feels that way. Almost every bar I have ever been to in Slovenia’s Capital allows smoking cannabis, or at least turns a blind eye to it. Is cannabis technically legal in Slovenia? No. However, small amounts are decriminalized, and it seems like it’s only a matter of time until Slovenia opens up a taxed and regulated adult use-market.

Being in Slovenia is like being dropped into a fairy tale, as it is consistently rated a top-ten “safest country in the world” by all the major indices. One would be hard pressed to find a more intelligent, vibrant, rational and sophisticated nation than the tiny, quaint and civilized, 2 million person mountain-nation of Slovenia. There is no doubt that the citizens of Slovenia are ready to legalize cannabis. It makes perfect sense.

Research Nature Institute Bringing Cannabis Healthcare Seminar To University Of Ljubljana

The cannabis plant is arguably the most helpful plant on earth, especially when it comes to wellness benefits. Cannabis, and the cannabinoid-based products derived from it, have been found to effectively treat numerous health conditions, as evidenced by a growing body of peer-reviewed research and patient experiences.

Unfortunately, many in the healthcare field are not as knowledgeable about the cannabis plant and its wellness properties as they should be. Given how prevalent cannabis use is in society, particularly for medical purposes, it’s vital that members of the healthcare community know the science behind the cannabis plant and how to use it effectively to treat various conditions.

An amazing opportunity to learn more about cannabinoids and their role in healthcare is coming to the University of Ljubljana later this month. The Research Nature Institute, in conjunction with university faculty, is hosting a two-part cannabis healthcare seminar on October 19th and 26th.

The two-part seminar at the University of Ljubljana is the second event of its type at the institution, with a prior seminar taking place back in May. It is the third education event by the Research Nature Institute recognized by the Medical Chamber of Slovenia and the Chamber of Nurses of Slovenia.

Topics to be covered during the seminar later this month include:

– information as facts – and separate it from misinformation,
– the situation in the field of medical use of cannabis in Slovenia,
– policy in the field of cannabis and cannabinoids in Slovenia and in the world,
– clinical approaches to cannabis therapies in Israel,
– theory and the practice of using cannabis with medical vaporizers,
– methods and success of using cannabis among older adults in the world,
– methods of applying cannabis to healthy and sick populations,
– experiences of treatment with cannabinoids in Germany,
– experiences with cannabis in complementary medicine (Israel).

The seminar’s program will include world class speakers, which is itself a testament to the quality of the seminar, as well as a testament to the increased international cannabis community focus on Slovenia and the greater Balkan region.

The event will be moderated by journalist Mr. Gorazd Rečnik and will be available online in addition to in-person, so everyone around the globe is encouraged to attend. You can find out more, and register, at the seminar’s webpage on the university’s website.

***

About the Research Nature Institute

The Research Nature Institute researches the efficacy and safety of natural remedies that are currently available or are of limited access to persons in need. By setting standards for quality control and standardization, providing accreditation programs, and taking part in clinical trials, the Research Nature Institute aims to ensure natural remedies are clean (free of contaminants) and effective at known dosages to the user. Underlying its mission is to educate the public, medical professionals and legislators of its findings based on sound scientific methodologies and principles.

German Federal Court Of Justice Upholds CBD Flower Convictions

Germany’s Federal Court of Justice issued a decision this week that could have potentially huge ramifications for the nation’s emerging cannabidiol (CBD) industry. Two defendants were originally convicted in 2021 in a lower court in Berlin for selling large quantities of CBD flower, and that decision was upheld by the higher Court.

Low-THC cannabis flower that is high in CBD is widely available in not only Germany, but throughout Europe. ‘Cannabis light,’ as it is often referred to, contains very little THC, which is what the defendants were buying and selling. Unlike THC, CBD is not associated with inducing intoxicating effects among those that consume it.

Unfortunately, the lower court was not swayed by any of the defendant’s arguments, and neither was the Federal Court of Justice. Below is a press release from the Federal Court of Justice regarding the decision, translated from German to English.

It contains the details regarding the Court’s legal reasoning behind its decision, which seems to be resulting in a lot of head scratching among the international cannabis community. At the very least, the decision will likely send some level of a chilling effect across Germany’s emerging CBD industry, as the legal reasoning can also be applied to a large number of other people and entities.

This decision further highlights the need for comprehensive cannabis policy reform in Germany:

The Leipzig-based 5th Criminal Division of the Federal Court of Justice has rejected the appeals of two defendants against a Berlin judgment in which they were sentenced to imprisonment in particular for trading in CBD flowers.

The Berlin Regional Court sentenced one of the accused to total imprisonment of three years, nine months and ten months (the execution of which it suspended on probation) for, among other things, gang dealing in large quantities of narcotics in two cases and the other for aiding and abetting in this.

According to the judgment of the district court, the main defendant – with the support of the second defendant and an unknown third party – acquired 60 kg of cannabis plant flowers with a high proportion of the active ingredient cannabidiol (CBD) in September and October 2019. He sold the CBD flowers to wholesalers for a profit, who in turn sold them to late sales outlets and CBD shops.

The comprehensive review of the judgment prompted by the factual complaint did not result in any legal errors to the detriment of the accused. In particular, the district court rightly classified the CBD flowers as narcotics within the meaning of Annex I to the Narcotics Act (BtMG). The flowers did not fall under a cannabis exemption. They did have an active ingredient content of 0.2% THC and thus did not exceed the limit specified in the exemption. However, there was no requirement that abuse for intoxicating purposes must be ruled out. If the flowers were heated during baking, for example, this led to the release of further THC, which could produce a cannabis intoxication when consumed by the end user. The main defendant was aware of this, but his assistant was indifferent.

Contrary to the opinion of the appeal, the conviction for trading in CBD flowers does not constitute a violation of the free movement of goods under European law (Art. 34 TFEU) that the flowers were legally produced in Spain. Because the flowers were narcotics, with which trade is prohibited from the outset and which are therefore not subject to the free movement of goods. The standards of European law on which this assessment is based were so clear according to the relevant legal norms and so far clarified by the case law of the Court of Justice of the European Union (ECJ) that there was no reason to obtain a decision from the ECJ on compatibility with European law (Art. 267 TFEU ).

In view of the possibility of a health-endangering misuse of CBD flowers for intoxication purposes, the Senate did not see any violation of the constitutional prohibition on excess in the punishability of trading in them.

The judgment of the Berlin Regional Court is now final.

Lower court :

LG Berlin – Judgment of July 7, 2021 – (510 KLs) 254 Js 38/20 (9/20)

The relevant regulations are:

Annex I to § 1 Para. 1 BtMG (non-marketable narcotics)

Cannabis (marijuana, plants and plant parts of plants belonging to the genus Cannabis)

– except (…)

b) if (…) their tetrahydrocannabinol content does not exceed 0.2 percent and they are used (except for cultivation) exclusively for commercial or scientific purposes that exclude misuse for intoxicating purposes. (…)

Art. 34 TFEU Ban on import restrictions

Quantitative import restrictions and all measures having equivalent effect are prohibited between Member States.

Art. 36 TFEU exceptions

(1) The provisions of Articles 34 and 35 shall not preclude import, export and transit bans or restrictions which (…) are justified to protect human health and life (…).

2. However, such prohibitions or restrictions shall not constitute a means of arbitrary discrimination or a disguised restriction on trade between Member States.

Article 267 TFEU

(1) The Court of Justice of the European Union decides by way of a preliminary ruling

a) on the interpretation of the contracts,

b) on the validity and interpretation of the acts of the Union institutions, bodies, offices or agencies. (…)

(3) If such a question is raised in pending proceedings before a national court, the decisions of which are themselves no longer subject to appeal under national law, that court shall be bound to refer the matter to the Court of Justice.

Karlsruhe, October 12, 2022

Argentina Issues First-Ever Domestic Cannabis Production License

The battle to legalize medical cannabis in Argentina has been waged for several years now. Argentina initially passed a medical cannabis legalization measure back in 2017, however, that legislation proved to be largely symbolic due to former President of Argentina Mauricio Macri who did basically everything in his power to hinder the nation’s medical cannabis program from progressing.

The current President of Argentina, Alberto Fernández, issued a decree back in 2020 that greatly increased safe access in the South American country. The decree legalized home cultivation, and also set the stage for Argentina’s legal cannabis industry to emerge, although the home cultivation provision had to be litigated later.

The decree also allowed pharmacies to sell cannabis-derived oils, topicals, and other products, and it directed insurance systems to cover medical cannabis treatments for patients who obtained a prescription, although further rulemaking needed to occur.

The cannabis industry in Argentina still needed one very important thing in order to launch – the issuance of the nation’s first domestic production license. That finally occurred this month. Per elm strador (translated to English):

The Government of Argentina has authorized the operation of a medical cannabis production plant in the northern province of Jujuy, which will become the first to manufacture this product in the South American country, official sources reported Tuesday.

The National Administration of Medicines, Food and Technology (ANMAT) of Argentina authorized the company Cannava, owned by the provincial state of Jujuy, to operate a plant with the capacity to annually process 80 tons of medicinal inflorescences and about 4,000 kilos of active pharmaceutical ingredients.

Argentina’s current president once predicted that the nation’s cannabis industry could support over 10,000 jobs. The issuance of the first license will obviously not yield that result on its own, however, it’s a major step in the right direction.

The South American country is the second largest by physical size on the continent, only behind Brazil. Argentina is home to roughly 41 million people, making it the third most populous country in South America.

President Of Colombia Applauds U.S. Cannabis Pardon Announcement

Last week United States President Joe Biden announced a plan to pardon people convicted of federal cannabis possession charges. It is estimated that the decision will affect roughly 6,500 people.

One question that seems to be lingering out there is what happens to future federal cannabis enforcement practices? Will people still be subjected to arrest and federal charges if/when they are caught possessing cannabis on federal property in the U.S.?

Only time will tell if that proves to be the case. Regardless, cannabis still remains a Schedule I substance in the U.S., although part of President Biden’s announcement involved tasking leaders of his related departments to examine cannabis’ current federal classification level.

The move by President Biden is being criticized by some and being hailed by others. One person that is giving praise to the decision is current the current president of Colombia, Gustavo Petro.

“The White House takes a fundamental step to change the vision of the fight against drugs. The user of marijuana will not be treated as a criminal.” President Petro tweeted days after the announcing of pardons (translated to English).

Cannabis reform is on the move in Petro’s country in addition to other parts of the planet. Colombian lawmakers recently approved a cannabis legalization measure in committee, which is something that President Petro has pushed for. The measure has a long road ahead, however, the fact that it was approved at the committee level is encouraging.

Colombia has long served as a top source for unregulated cannabis, and continues to be so to some extent. Fortunately, there are people in the country working to get the nation on the right side of history, not the least of which is the country’s president.